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Distal revascularization–interval ligation:
A durable and effective treatment for ischemic
steal syndrome after hemodialysis access
Robert C. Knox, MD, Scott S. Berman, MD, FACS, John D. Hughes, MD, FACS,
Andrew T. Gentile, MD, and Joseph L. Mills, MD, FACS, Tucson, Ariz
Purpose: The treatment of hemodialysis access–induced ischemic steal syndrome is challenging. Despite promising early
results with the distal revascularization–interval ligation (DRIL) procedure, the operation has not been widely adopted
because of concerns about its complexity and long-term efficacy. The purpose of this report was to determine the efficacy
and durability of the DRIL procedure in relieving hand ischemia and in maintaining access patency in the setting of
hemodialysis access–induced ischemia.
Methods: A retrospective review was performed of all patients who underwent the DRIL procedure for access-induced
ischemia. Demographic information was compiled, as were data regarding access and bypass patency, limb salvage, and
patient survival. Arteriovenous access and brachial artery bypass patency rates were determined with life-table methods.
Results: Between 1995 and 2001, we performed 55 DRIL procedures in 52 patients (35 women and 17 men; mean age,
60.8 years; range, 30 to 86 years). The indications for surgery were ischemic pain in 27 patients, tissue loss in 20 patients,
loss of neurologic function in four patients, and pain on hemodialysis in one patient. Most patients (92%) had diabetes.
The mean interval from access placement to DRIL was 7.4 months (range, 1 to 84 months). The mean follow-up interval
was 16 months (range, 1 to 67 months). The brachial artery bypass primary patency rate was 80% at 4 years, and the
arteriovenous access primary patency rate was 83% at 1 year. Forty-seven of 52 patients (90%) had substantial or complete
relief of ischemic hand symptoms, and 15 of 20 patients with digital ischemic lesions have healed completely.
Conclusion: DRIL is a durable and effective procedure that reliably accomplishes the twin goals in the treatment of
angioaccess-induced ischemia: persistent relief of hand ischemia and continued access patency. (J Vasc Surg 2002;36:
250-6.)
The prevalence of patients in the United States with
end stage renal disease (ESRD) is steadily increasing,
largely because of the widespread availability of hemodial-
ysis. An estimated 200,000 patients are currently undergo-
ing hemodialysis.1 The most common reason patients with
ESRD come in contact with the healthcare system is related
to complications of hemodialysis access,2 most frequently
because of access thrombosis.3 A less common but most
difficult complication of vascular access for successful treat-
ment is extremity ischemia related to an otherwise ade-
quately functioning access. Extremity ischemia may de-
velop as the result of the phenomenon of steal, in which not
only is significant arterial blood flow shunted directly into
the venous outflow of an arteriovenous fistula or graft but
also a portion of the collateral flow to the distal extremity is
“stolen” by the access. Approximately 80% of patients with
a functional arteriovenous access are estimated to have
physiologic steal (ie, a demonstrable reduction in distal
perfusion pressure). Physiologic steal is usually compen-
sated by multiple mechanisms, including the development
of abundant arterial collaterals and distal vasodilatation.
However, if these mechanisms are insufficient to maintain
adequate distal perfusion pressure, ischemic steal syndrome
(ISS) or clinically significant steal develops.4 True ISS
develops in only 6% to 8% of patients undergoing hemodi-
alysis.5,6 This report, which includes some of the patients
from our previously reported series, reviews our long-term
experience with the use of the distal revascularization–
interval ligation (DRIL), as originally described by Schan-
zer et al,7,8 to address this difficult problem.9
METHODS
A retrospective review was conducted of patients who
underwent the DRIL procedure at University Medical
Center, St Mary’s Hospital, and Northwest Medical Center
in Tucson, Ariz. Demographic data were compiled and
included the type of arteriovenous access associated with
the steal syndrome, the etiology of the ESRD, and patient
gender, race, age, and comorbid conditions, such as hyper-
tension, diabetes, and tobacco abuse. The indications for
the DRIL procedure were tabulated and included persis-
tent hand pain during dialysis treatments, rest pain, loss of
neurologic function, and tissue loss. The time from the
placement of the index access (access responsible for ISS) to
the onset of symptoms was recorded. Additional note was
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made of the recipient artery of the DRIL procedure, the
type of bypass conduit, the outcome of the DRIL proce-
dure concerning symptom relief, and procedure-related
complications.
Any noninvasive vascular laboratory testing performed
before the DRIL procedure and during subsequent fol-
low-up was reviewed (Fig 1). As part of the routine evalu-
ation for steal syndrome, all patients underwent arteriogra-
phy with and without compression of the arteriovenous
access (Fig 2). Performance of the DRIL procedure was
similar to that described originally by Schanzer et al7 and
subsequently reported by Berman et al.9 In brief, a bypass
constructed of reverse autogenous vein was anastomosed to
the brachial artery at least 3 cm proximal to the origin of the
arteriovenous access.4 This graft then was anastomosed
distally in the forearm to either the brachial, radial, or ulnar
artery. The recipient artery then was ligated just proximal to
the distal bypass anastomosis to eliminate direct retrograde
flow toward the fistula (Figs 3 and 4).
Primary patency rates of the DRIL procedure and the
index access procedure were calculated with life-table
methods. Data comparisons were performed with 2 and
Student t tests where appropriate. Statistical analyses were
performed with Statview software (Abacus Concepts Inc,
Berkeley, Calif).
RESULTS
Between January 1995 and May 2001, we performed
1138 primary hemodialysis access procedures in 599 men
and 539 women. During this period, we performed 55
DRIL procedures in 52 patients for an overall ISS incidence
rate of 4.6%. Pertinent demographic data are summarized
in Table I. Only two patients had ESRD resulting from
conditions other than diabetes mellitus or hypertension. In
these latter patients, ESRD was attributed to systemic lupus
erythematosus and multiple myeloma. The indications for
the DRIL procedure included 27 patients (52%) with rest
pain, 20 patients (38%) with tissue loss, four patients (8%)
with loss of neurologic function, and one patient (2%) with
persistent pain during dialysis treatments. DRIL was per-
formed in more than twice as many women as men, and
Hispanic women comprised the largest subgroup of pa-
tients, accounting for 42% of the entire series. In fact, the
incidence rate of ISS in our series by gender was 2.8% in
men and 6.5% in women. Women were statistically more
likely than men to have rest pain as the indication for the
DRIL (P  .04; 2  8.1); 60% of women had rest pain
compared with only 35% of men. The primary indication
for DRIL in men was tissue necrosis (59%).
The index access procedure resulting in the steal syn-
drome included 19 brachiocephalic arteriovenous fistulae
(36.5%; Kaufman), 19 upper arm expanded polytetrafluo-
roethylene (ePTFE) arteriovenous grafts (36.5%), 12 fore-
arm ePTFE arteriovenous grafts (23%), and two basilic vein
Fig 1. Digital plethysmography of patient with severe ISS. Left, Monophasic digital waveform with patent uncom-
pressed arteriovenous fistula. Right, Markedly improved digital waveform with fistula compression.
Fig 2. Upper extremity arteriogram in patient with polytetrafluo-
roethylene forearm loop arteriovenous fistula and ischemic rest
pain. A, Without compression, no filling of infrabrachial arteries is
seen. B, With manual compression, forearm vasculature is well
demonstrated.
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transposition arteriovenous fistulae (4%). Three of the 19
upper arm grafts were constructed with 4-mm to 7-mm
tapered ePTFE grafts. All these fistulae were based on
brachial arterial inflow. The men who needed DRIL were
more likely to have a native fistula than were the women
(P  .02; 2  11.8). The mean interval from access
placement to onset of ischemic symptoms was 7.4  1.6
months, with a range of 0 to 84 months.
Most patients (78%) received bypass grafts comprised
of reversed greater saphenous vein, with 36 (65%) har-
vested from the thigh and seven (13%) harvested from the
calf or ankle. Eleven bypasses (20%) were constructed with
reversed cephalic vein, and one (2%) was performed with
lesser saphenous vein. The distal bypass anastomotic inser-
tion sites were the brachial artery in 24 cases (44%), the
radial artery in 20 cases (36%), and the ulnar artery in 11
cases (20%). In five cases (9%), significant wound compli-
cations developed. These occurred at the site of saphenous
vein harvest in four patients (7%) and at an antecubital
incision in one patient (2%). No other significant peripro-
cedural complications occurred.
The DRIL procedure successfully alleviated ischemic
symptoms in 47 of 52 patients (90%). In three patients, the
DRIL failed to adequately resolve the ischemia and access
ligation was necessitated. In three other patients, a second
Fig 3. Diagram of upper arm brachiocephalic fistula and brachial
artery bypass with interval brachial artery ligation. In this case,
brachial artery was divided below origin of fistula and distal anas-
tomosis of vein bypass graft was performed end-to-end to distal
brachial artery.
Fig 4. Completion arteriogram shows both forearm loop arterio-
venous (AV) fistula and brachial artery bypass.
Table I. Demographic data of patients for DRIL (n 
52)
Age (y)* 60.8  10.7 years
Women 35 (67%)
Men 17 (33%)
Race
Hispanic 24 (46%)
Native American 15 (29%)
White 10 (19%)
African American 3 (6%)
Etiology of ESRD
DM/HTN 26 (50%)
DM 23 (44%)
HTN 1 (2%)
Other 2 (4%)
*Data expressed as mean  standard deviation.
DM, Diabetes mellitus; HTN, hypertension.
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DRIL procedure was successfully performed after the first
DRIL failed because of graft thrombosis. These patients all
had recurrent symptoms develop marked by rest pain. After
repeat bypass, these three patients had resolution of their
symptoms. The period of primary patency of the initial
DRIL procedure in these three latter patients was 8.7
months. In two patients, no improvement in symptoms was
seen, but access ligation was not necessitated. These pa-
tients were believed to no longer have symptoms related to
steal but rather as the result of ischemic monomelic neu-
ropathy. Postoperative noninvasive testing, which showed
pulsatile digital arterial waveforms, significant improve-
ment in digital pressures, and abnormal nerve conduction
studies, supported this diagnosis. The outcomes of the
DRIL procedures appear in Table II, which tabulates out-
come versus indication.
The primary life-table patency rates of the index access
procedure causing the ISS were 83% at 12 months and 71%
at 36 months. No significant difference was seen in primary
patency between upper arm prosthetic arteriovenous grafts,
forearm loop arteriovenous grafts, and native arteriovenous
fistulas at 12 months with the log-rank analysis (89% versus
82% versus 74%, respectively; P  .36). The primary pa-
tency rates of the DRIL procedure with life-table methods
were 86% at 12 months and 80% at 48 months. Life-table
patient survival rates were 86% at 12 months and 56% at 48
months.
DISCUSSION
The maintenance of vascular access for hemodialysis is
the single most valuable component of renal replacement
therapy, in terms of both patient morbidity and costs. The
most common reason for a patient with ESRD to need
medical care is for maintenance of hemodialysis access.2
Access thrombosis is the usual reason for access failure and
can be readily treated with thrombectomy or revision of the
access with predictable success rates.10 Access-induced
ischemia, however, is a less commonly encountered access
complication and presents dual challenges to the clinician:
(1) resolving the ischemia and (2) maintaining the access.
Access-induced ischemia is considered to occur because
of “stealing” of perfusion from the distal extremity. Not
only does the fistula consume the antegrade flow in the
artery at the level of the fistula, it also “steals” a portion of
the distal arterial collateral flow via retrograde flow from the
native artery distal to the fistula origin.4 Physiologic steal,
or steal that is clinically silent, has been shown to be nearly
universal and reportedly occurs in 80% to 94% of arterio-
venous accesses.5,11 Lazarides et al11 prospectively mea-
sured systolic pressure index (SPI; systolic forearm pressure
in the index arm distal to arteriovenous fistula divided by
the contralateral arm systolic pressure) in 69 consecutive
patients. Ninety-four percent of these patients had SPI less
than 0.8, and the mean SPI 24 hours after fistula creation
was 0.55. Most of these patients were asymptomatic, how-
ever, and by 11 months after fistula creation, the mean SPI
had risen to 0.74. This gradual improvement in SPI is the
result of compensatory distal arterial vasodilation and the
progressive development of a rich arterial collateral network
around the fistula. A large arteriovenous fistula is a most
potent stimulus for such collateral arterial development.
Although physiologic asymptomatic steal is nearly uni-
versal, clinically significant steal develops only when inher-
ent compensatory mechanisms are inadequate to maintain
or restore distal arterial perfusion pressure to a level suffi-
cient to meet peripheral metabolic requirements. Clinically
significant steal, manifest as either severe pain in the hand,
tissue loss, or loss of hand function, is much less prevalent.
Several retrospective reviews showed an incidence rate of
ISS between 1% and 8%.5,11-13 Goff et al6 prospectively
identified clinically significant steal needing intervention in
6% of patients who underwent arteriovenous access con-
struction. In a similar prospective study examining intraop-
erative digital brachial indices, we identified a similar inci-
dence rate of significant steal of 6% in 100 consecutive
arteriovenous access patients (Berman SS, Gentile AT, un-
published data, 2000). The factors that contribute to clin-
ically significant steal remain somewhat elusive. Some risk
factors have been identified, such as female gender, age
more than 60 years, diabetes mellitus, construction of an
autogenous fistula, and brachial artery inflow.4 The preva-
lence of these factors is supported with this report. How-
ever, the inability to accurately and prospectively predict
the development of steal solely on the basis of initial post-
operative measurements of digital perfusion highlights the
complexity of the problem.
Once severe steal has been identified, a number of
options for treatment have been proposed. Ligation of the
arteriovenous access universally eliminates the ischemia
problem but with a significant penalty—loss of the access.
Although the ischemia is resolved, a new access route for
the patient to continue renal replacement therapy must be
Table II. Outcome of DRIL procedure versus indication
Outcome
Indication for DRIL (n  55)
Rest pain Tissue loss Loss of function Pain on HD Totals
Complete relief 16 10 3 1 30 (55%)
Improved 9 4 1 0 14 (25%)
No change 2 0 0 0 2 (4%)
Healed amps 0 6 0 0 6 (11%)
Failure/ligated 1 2 0 0 3 (5%)
HD, Hemodialysis; amps, amputations.
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created. Ligation does have a role to play in access-induced
ischemia, although in a limited, defined circumstance.
When severe ischemia occurs distal to a radiocephalic (Bres-
cia-Cimino) arteriovenous fistula at the wrist, ligation of
the distal radial artery effectively eliminates the steal with-
out adversely impacting the access. In our own experience,
this technique has been used on only two occasions (not
included in this series) with complete relief of ischemia.
Another technique designed to treat access-induced
ischemia is banding of the access. Banding is based on the
premise that increasing fistula resistance will indirectly in-
crease perfusion to the extremity distal to the fistula origin.
By incrementally increasing the resistance in the access, the
relative resistance of the peripheral arterial bed is decreased.
However, fistula flow is related to fistula diameter only for
small arteriovenous fistulae. This relationship is nonlinear,
and a recent review by Wixon et al4,14 draws comparisons
between the physiology of the arteriovenous access compo-
nents and the electrical resistance of a Wheatstone bridge.
On the basis of these considerations, banding an arterio-
venous fistula would increase the total resistance of the
circuit, and banding sufficient to reliably alleviate steal
would be predicted to reduce fistula flow to the point of
thrombosis.
The reported clinical experience with banding has been
mixed but generally poor. A number of authors have re-
cently promoted the use of intraoperative perfusion mea-
surements during the banding procedure to quantify the
degree of banding needed to achieve the delicate balance.
Odland et al15 recently reported a series of patients treated
with banding with intraoperative photoplethysmography.
In this report, the targeted endpoints of banding were a
digital arerial pressure of 50 mm Hg or digital/brachial
index of 0.6. With this strategy, they achieved access pa-
tency rates of 62.5% at 6 months and 38.5% at 12 months.
In a smaller series of five patients, Rivers et al16 used pulse
volume recordings during surgery to gauge the degree of
plication needed to improve distal perfusion. All five pa-
tients had resolution of ischemic symptoms and maintained
a functional access when the pulse volume recordings were
increased by 5 mm or more. A palpable radial pulse was
restored in only three patients, however, and long-term
relief of steal was not documented. Finally, in a review by
DeCaprio et al17 of all patients with steal syndrome during
a 3-year period, banding was used in 11 of 18 patients. In
all but one of these patients, the fistula occluded within 6
months of banding.
These results highlight the inherent problem with
banding techniques: inconsistent and unreliable success in
maintaining access patency. In general, banding the access
sufficiently to relieve ischemia usually leads to access throm-
bosis. In the early 1980s, a tapered ePTFE graft was intro-
duced to reduce access-induced ischemia.18 By interposing
a smaller arterial end to a larger venous end, net access
resistance would be increased. Unfortunately, the initial
enthusiasm for the tapered graft has been tempered by a
lack of clinical efficacy in reducing access-induced ischemia.
In our own series reported herein, we placed a total of 30
tapered grafts during the study period for prevention of
steal; three patients with upper arm–tapered arteriovenous
grafts had significant steal develop. Again, both banding
and tapered grafts have the same physiologic flaw: they
increase fistula resistance. Predictably, increasing fistula
resistance will not reliably prevent or treat ISS, although it
may reduce access patency.
The concept of treating significant access-induced is-
chemia with a bypass graft and ligation of the artery be-
tween the fistula and the bypass was first reported by
Schanzer et al7 in 1988. Despite their initial success with
three cases, the technique was not widely adopted. Schan-
zer et al8 and Haimov et al19 subsequently reported their
experience with an expanded series of 14 patients in 1992
and 23 patients in 1996. Success was achieved in 13 of 14
patients in the first series. In the 1996 series, they showed
improvement in all 23 patients who underwent the DRIL
procedure, with a bypass patency rate of 95.6% at 2 years.
Unfortunately, despite these reports of near universal suc-
cess in relieving the ischemia and maintaining access pa-
tency, this technique still received little recognition. Katz
and Kohl20 subsequently published a small series of six
patients treated with revascularization and ligation with
similar success. The premise behind the procedure is sim-
ple, elegant, and physiologically sound. The bypass graft
functions as a large low-resistance arterial collateral and
improves perfusion pressures in the antebrachial arteries
distal to the arteriovenous access. The interval ligation
eliminates the pathway for flow reversal and therefore steal
with its placement between the access origin and the distal
bypass anastomosis.
We embraced this technique in 1994 and subsequently
published what was then the largest series of patients who
underwent this procedure.9 In this report, we coined the
acronym DRIL to describe the critical components of
the procedure. Since that publication, the awareness of the
DRIL procedure as a superior alternative to banding or
ligation has become evident. However, what was lacking
both in our previous report and in those of other investiga-
tors were long-term data regarding the durability of the
DRIL procedure in both relieving the ischemia and main-
taining access patency. In simple terms, is a procedure of
this magnitude and complexity durable enough that it
should be used as the procedure of choice for access-
induced ISS?
This report not only provides the largest reported ex-
perience to date with the DRIL procedure but also estab-
lishes the durability of the technique in fulfilling the dual
challenges of access-induced ISS. In this report, 47 of 52
patients (90%) showed significant or complete symptom-
atic improvement. Three patients needed access ligation
after failing to show adequate resolution of symptoms
despite a patent bypass. The failure in these patients is
possibly caused by concomitant small vessel disease. The
proximity of the bypass origin to the origin of the access
and therefore its pressure sink region may also have ad-
versely affected these patients. Only two patients with rest
pain had no improvement in symptoms despite noninvasive
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Doppler testing showing resolution of steal with markedly
improved digital arterial pressures. These patients were
thought to have ischemic monomelic neuropathy.21 All
patients with tissue loss have healed or healing lesions.
Prosthetic arteriovenous grafts have a reported 12-
month primary patency rate of 40% to 50%, with native
arteriovenous fistulae achieving a primary patency rate of
80% at 12 months.22,23 In this report, the 12-month actu-
arial primary patency rate of prosthetic arteriovenous grafts
was nearly 85%. The superior arteriovenous graft patency in
this subgroup of patients is likely the result of selection bias.
The fistulae had been patent for a mean interval of more
than 7 months before ISS developed and therefore repre-
sent well-functioning, stable fistulae. In addition, patients
with significant steal characteristically have high flow fistu-
lae. The DRIL procedure, with a 48-month primary pa-
tency rate of 80%, reliably improved distal perfusion with-
out sacrificing significant fistula blood flow. These
considerations likely account for the high primary patency
rate of the prosthetic arteriovenous grafts in our series.
A number of issues remain unclear in the treatment of
patients with arteriovenous access-induced ISS. Foremost
is the problem of identifying patients at risk. To date, no
preoperative or intraoperative measure of extremity perfu-
sion can accurately and consistently predict which patients
will have ISS develop. This problem likely relates to the
variability of collateral flow to the hand around the ante-
brachial arteries. This issue also impacts the design of the
DRIL procedure and the choice of distal target artery for
the bypass. We generally prefer to perform the distal anas-
tomosis to the brachial artery, especially if there is at least
one continuous vessel to the hand. In this series, 42% of the
bypasses were inserted into the brachial artery, and 37% and
24%, respectively, were inserted into the radial and ulnar
arteries. This decision was usually based on preoperative
angiography, and the most dominant vessel supplying the
hand was chosen. The variability of the forearm and palmar
arterial blood supply necessitates careful attention to pre-
operative angiography and completion angiography at the
time of the DRIL procedure.
Angioaccess-induced ISS is an infrequently encoun-
tered complication in patients with ESRD. Successfully
treating significant steal poses dual challenges: maintaining
access patency and eliminating the ischemia. Of the avail-
able treatment options, the DRIL procedure provides the
method that most reliably accomplishes these twin goals.
This report also substantiates the long-term durability of
the DRIL in the management of these complicated cases.
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DISCUSSION
Dr Wayne Gradman (Los Angeles, Calif). Dr Knox and his
colleagues have reviewed 55 DRIL procedures performed over a
6-year period. All fistulas were based on the distal brachial artery.
They report an impressive 4-year primary patency rate for the distal
bypass of 80% and substantial or complete relief of ischemia or
tissue necrosis in 90%. Nonetheless, an average approaching one
DRIL procedure per month strikes me as rather high, and so it
would be of interest to learn the incidence of the DRIL procedure
in your access population.
Two reasons for such a high incidence might be a failure first,
to identify patients at risk and take steps to mitigate the steal at the
time of the initial surgery, and second, to consider other options
when one develops. You have shown that diabetes and hyperten-
sion are associated with but not predictive of a steal syndrome, but
shouldn’t anatomic factors be more important? What do you do
when you encounter a tiny or diseased brachial artery on explora-
tion? What advice do you have for the surgeon if wrist pulses
disappear immediately following construction of an access and the
hand appears suspiciously pale? In other words, do you ever
perform DRIL on the spot, or do you always take a wait-and-see
approach?
While you note that tapered grafts did not prevent a clinical
steal in three of your patients, the remaining 16 of your 19
upper-arm PTFE grafts were untapered. In our experience, 4- to
6-mm or 4- to 7-mm grafts with the arterial end tapered to 4.5 or
5.0 mm do indeed reduce the incidence of steal syndromes and
seldom thrombose because of arterial inflow problems.
Once an ischemic steal syndrome develops, you may ask what
is so objectionable about proceeding directly to a DRIL procedure,
our de facto “gold standard.” Well, only in Tucson do surgeons
ligate a perfectly normal artery so they can do a saphenous vein
bypass, without at least some remorse. In addition, it appears you
also advocate prepoperative and intraoperative arteriography.
DRIL proponents act smug because the only widely acknowl-
edged alternative to the DRIL procedure is fistula banding, which
produces frequent graft thrombosis and therefore is justifiably
maligned. Treatment of the steal syndrome begs for reasonable
alternatives besides DRIL, so I would like to offer three for your
consideration and comment.
In this manuscript, you describe your technique as construct-
ing the bypass first, then ligating the intervening artery. Have you
ever stopped to assess the circulation to the hand before you ligate
the interval artery? The bypass by itself functions as a giant collat-
eral and usually restores the wrist pulses that were presumably
present before the initial surgical procedure, thus obviating the
need for interval ligation. Distal flow is even greater if you don’t
have to cross the elbow and you can use 6-mm PTFE instead of
vein. The high retrograde flow at the distal anastomosis keeps the
PTFE bypass open. I have yet to ligate the intervening artery when
I use PTFE for the bypass.
Another effective operation in steal patients with high-flow
autogenous vein fistulas (say, greater than 1000 cc/minute) is to
disconnect the arterial anastomosis, cut a triangular wedge out of
the vein, and reimplant it with a 4.5- or 5-mm tapered anastomosis.
Such a tapered conduit behaves quite differently from one that is
banded in situ, in that it is much less likely to clot. The increase in
hand flow is proportional to the increase in fistula resistance.
Finally, my favorite operation is to construct a loop fistula
based on the axillary artery. A loop axillary fistula is topologically
equivalent to the DRIL procedure. Conversion of a straight upper-
arm graft to a loop axillary graft dramatically increases flow in both
the fistula and the distal arm, even though the literature and
intuition suggest that distal arm flow should decrease. This proce-
dure is especially useful in the intraoperative period to avoid a steal,
and in the immediate postoperative period to correct one.
Although these three procedures increase distal arm flow less
than DRIL, they are clinically quite effective at reversing steal
symptoms. It is indeed possible to create large numbers of access
procedures and never need to ligate a normal brachial artery or
harvest saphenous vein.
I did enjoy reading your manuscript. Your work remains an
important benchmark for all studies of the steal syndrome and its
treatment.
Dr Robert Knox. First, I would like to thank Dr Gradman
for his thoughtful comments. To answer your first question, we
have found that the incidence of ischemic steal syndrome (ISS) in
our patient population is in line with that reported in the literature.
Approximately 10% of our arteriovenous access patients develop
some element of clinical steal, the majority of which are mild and
resolve with time as the patient develops collaterals. Approximately
5% to 6% of our patients develop symptoms severe enough to
require intervention.
After fistula placement, we routinely evaluate hand perfusion
with continuous-wave Doppler. In our experience, the absence of
a pulse far exceeds the incidence of severe steal and is therefore not
an accurate predictor of problems. Those with no audible radial or
ulnar Doppler flow would undergo immediate intervention; one
patient in our series underwent an immediate DRIL procedure.
We perform preoperative angiography on all of our DRIL
patients. This is necessary to facilitate choosing an adequate target
vessel. In addition, if the patient has a stenosis in the inflow artery,
we would treat that lesion without performing a DRIL procedure.
We do not routinely perform intraoperative angiography.
Our group has unpublished data in which we performed the
distal bypass and measured pressures prior to brachial artery liga-
tion. We found no consistent improvement in digital pressures. We
surmise this is because the patients will steal from the newly
constructed bypass as well. After interval ligation, however, the
digital pressures increase significantly. These observations are con-
sistent with Schanzer’s original findings. We acknowledge your
understandable hesitance to ligate a “normal” brachial artery.
However, this brachial artery segment is hemodynamically non-
functional due to the presence of reversed or to-and-fro flow.
Therefore, nothing is lost clinically, and the intended ligation
prevents retrograde flow from the newly constructed bypass back
up the fistula.
The techniques Dr Gradman describes function to increase
fistula resistance and theoretically may compromise fistula patency.
Our approach has been to concentrate on increasing distal blood
flow rather than increasing fistula resistance.
The critical question is how to predict who will develop severe
steal. We have identified risk factors such as female sex, diabetes,
and upper-arm AV fistulas but have not been able to accurately
predict the development of ISS prospectively in each individual
patient.
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